Simon Travis
- Genetics top 0.01%
- Inflammatory Bowel Disease 292
- Gastroenterology top 0.1%
- Gastrointestinal Bleeding Diagnosis and Treatment 27
- Epidemiology top 0.05%
- Microscopic Colitis 225
- Autoimmune and Inflammatory Disorders 35
- Immunology top 0.5%
- Immunodeficiency and Autoimmune Disorders 23
- Hepatology top 0.5%
- Liver Diseases and Immunity 22
-
- Eosinophilic Esophagitis 40
- Helicobacter pylori-related gastroenterology studies 39
- Co-authors
- Gert Van AsscheAxel DignaßMarkus F. NeurathEduard F. StangeWalter ReinischGerassimos J. MantzarisJames O. LindsayRobert V. Bryant
- Cited by
- GeneticsGastroenterologyEpidemiology
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Simon Travis
405 papers receiving 21.3k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Genetics 14.9k
- Gastroenterology 2.6k
- Epidemiology 11.7k
- Immunology 3.8k
- Hepatology 1.4k
Countries citing papers authored by Simon Travis
This map shows the geographic impact of Simon Travis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Travis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Travis more than expected).
Fields of papers citing papers by Simon Travis
This network shows the impact of papers produced by Simon Travis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Travis. The network helps show where Simon Travis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Simon Travis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 25 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 8 | |
| 8 | 2022 | 47 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 5 | |
| 11 | 2020 | 11 | |
| 12 | 2017 | 35 | |
| 13 | 2017 | 78 | |
| 14 | Mucosal healing in inflammatory bowel diseases: a systematic reviewbreakdown → | 2012 | 640 |
| 15 | Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trialbreakdown → | 2012 | 1156 |
| 16 | 2012 | 69 | |
| 17 | Early coagulopathy is associated with increased mortality and re-bleeding in non-cirrhotics with acute upper gastrointestinal bleeding | 2010 | 2 |
| 18 | 2009 | 0 | |
| 19 | Prevalence and determinants of primary sclerosing cholangitis in a cohort of patients with inflammatory bowel disease and normal liver function tests | 2008 | 6 |
| 20 | 1998 | 2 |
About Simon Travis
Simon Travis is a scholar working on Genetics, Gastroenterology and Epidemiology, having authored 433 papers that have together received 21.8k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (292 papers), Microscopic Colitis (225 papers), Eosinophilic Esophagitis (40 papers), Helicobacter pylori-related gastroenterology studies (39 papers), Autoimmune and Inflammatory Disorders (35 papers), Gastrointestinal Bleeding Diagnosis and Treatment (27 papers), Immunodeficiency and Autoimmune Disorders (23 papers) and Liver Diseases and Immunity (22 papers). The work is most often cited by research in Genetics (14.9k citations), Gastroenterology (2.6k citations) and Epidemiology (11.7k citations). Simon Travis has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Gert Van Assche, Axel Dignaß, Markus F. Neurath, Eduard F. Stange, Walter Reinisch, Gerassimos J. Mantzaris, James O. Lindsay, Robert V. Bryant, Alissa Walsh and Bryan F. Warren. Their work appears in journals such as Journal of Crohn s and Colitis, Gastroenterology, Gut, Alimentary Pharmacology & Therapeutics and Inflammatory Bowel Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.